Scarica l'app Stockscreener
9.59
3.57%
-0.355
Dopo l'orario di chiusura:
9.50
-0.09
-0.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.945
Aprire:
$9.9
Volume 24 ore:
788.85K
Relative Volume:
0.78
Capitalizzazione di mercato:
$823.72M
Reddito:
-
Utile/perdita netta:
$-43.16M
Rapporto P/E:
-17.44
EPS:
-0.55
Flusso di cassa netto:
$-29.31M
1 W Prestazione:
-15.51%
1M Prestazione:
-12.66%
6M Prestazione:
+10.23%
1 anno Prestazione:
+57.47%
Intervallo 1D:
$9.55
$10.03
Intervallo di 1 settimana:
$9.55
$11.70
Portata 52W:
$4.9301
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corporation
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Confronta AVXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.59 | 854.21M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.88 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.87 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.91 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
661.32 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.32 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
Anavex Life Sciences Corp. Attempts Reversal From Key Support2025 Short Interest & Trade Opportunity Analysis - newsimpact.co.kr
Can volume confirm reversal in Anavex Life Sciences Corp.Weekly Investment Report & Long-Term Safe Return Strategies - Newser
Why Anavex Life Sciences Corp. is moving todayJuly 2025 PreEarnings & Verified Technical Trade Signals - Newser
Visual analytics tools that track Anavex Life Sciences Corp. performanceEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - Newser
Real time social sentiment graph for Anavex Life Sciences Corp.Portfolio Performance Report & Daily Volume Surge Signals - Newser
Risk adjusted return profile for Anavex Life Sciences Corp. analyzedEarnings Recap Report & Smart Money Movement Tracker - Newser
Regression analysis insights on Anavex Life Sciences Corp. performanceMarket Volume Report & Detailed Earnings Play Strategies - Newser
Is Anavex Life Sciences Corp. a candidate for recovery playEarnings Recap Summary & Fast Entry High Yield Tips - Newser
What technical models suggest about Anavex Life Sciences Corp.’s comebackEarnings Trend Report & Expert Approved Momentum Ideas - Newser
What data driven models say about Anavex Life Sciences Corp.’s futureJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - Newser
Fibonacci Retracement Aligns with Support in Anavex Life Sciences Corp.2025 Technical Patterns & Precise Buy Zone Tips - sundaytimes.kr
Is Anavex Life Sciences Corp. Forming a Bottom Pattern2025 Market WrapUp & Free Daily Entry Point Trade Alerts - sundaytimes.kr
Chart overlay techniques for tracking Anavex Life Sciences Corp.Earnings Performance Report & Risk Controlled Stock Pick Alerts - Newser
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript - MSN
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at D. Boral Capital - Defense World
LPL Financial LLC Boosts Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
PNC Financial Services Group Inc. Has $495,000 Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Amends Executive Employment Contracts - MSN
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - Greenwich Time
Context Therapeutics Inc. shares fall 1.47% premarket after Anavex Life Sciences reports fiscal 2025 third quarter results. - AInvest
Anavex Life Sciences Reports Q3 2025 Financial Results - TipRanks
Can a trend reversal in Anavex Life Sciences Corp. lead to recoveryChart Signals & High Accuracy Swing Trade Signals - Newser
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Anavex Life Sciences shares fall 4.76% intraday after reporting a wider fiscal Q3 loss. - AInvest
Earnings call transcript: Anavex Life Sciences Q3 2025 sees R&D drop - Investing.com Nigeria
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update - The Globe and Mail
Anavex Life Sciences Corp. Q3 Loss Increases, Misses Estimates - Nasdaq
Anavex Life Sciences Fiscal Q3 Loss Widens - MarketScreener
Anavex Life Sciences Corp. Reports Q3 Fiscal 2025 Financial Results and Webcast Announcement - Quiver Quantitative
Earnings Flash (AVXL) Anavex Life Sciences Posts Fiscal Q3 Net Loss $0.16 a Share, vs. FactSet Est of $0.14 Loss - MarketScreener
Anavex Reports Breakthrough: Oral Alzheimer's Drug Maintains Benefits After 4 Years as Cash Position Tops $100M - Stock Titan
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
How high can Anavex Life Sciences Corp. stock goRSI and MACD Signal Summary with Trends - Newser
Understanding Anavex Life Sciences Corp.’s price movementSmart Trade Mapping with Entry Details - Newser
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSwing Watchlist With Tight Stop Placement - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Stock Entry Points Based on Technicals - Newser
Historical volatility pattern of Anavex Life Sciences Corp. visualizedEquity Portfolio Outlook and Performance Summary - Newser
Published on: 2025-08-10 02:07:10 - Newser
Can Anavex Life Sciences Corp. recover in the next quarterROI Focused Setup Screener With Exit Markers - Newser
How Resilient Is Anavex Life Sciences Corp. Stock During Economic DownturnsFree Risk Controlled Short Term Trade Plans - Newser
Is Anavex Life Sciences Corp. stock reversal real or fakeIntraday Price Forecast Using Volume Models - Newser
Will Anavex Life Sciences Corp. outperform the marketVolume Spike Detection for Early Breakouts - Newser
Envestnet Asset Management Inc. Sells 6,064 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):